Dr. Douglas B. Hornick, MD

Dr. Hornick practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Hornick's NPI, 1437147386, was assigned on October 13, 2005. Dr. Hornick graduated from University of Maryland School of Medicine in 1982. Dr. Hornick holds Iowa license 23749.

Dr. Hornick's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Hornick's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Hornick is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Hornick to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hornick practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Hornick's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Hornick is licensed in Iowa.

CMS data shows 1,586 Medicare services from Dr. Hornick across 11 procedure codes in 2024, for 792 Medicare patients. Medicare paid $39,063 for them.

CMS counts 792 Medicare patients who saw Dr. Hornick in 2024. The largest group is 65 to 74, with 384 patients. 71% of them have high blood pressure, and 65% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hornick's median patient age at 72, with 61% women.

In 2024, Dr. Hornick wrote 2,096 Medicare Part D claims for 192 patients. 71% of them were for generic drugs. CMS names the drug for 1,867 of them, across 43 drugs with 11 or more claims each, at $1,861,847 in total drug cost. In 2023, CMS named 1,556 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Hornick for performance year 2024, reported as part of a group. Dr. Hornick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Hornick, published from 2010 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator and Aminophenols. Dr. Hornick has published most often in Open Forum Infect Dis. Dr. Hornick's most frequent co-authors are David Anthony Stoltz, MD, Philip M. Polgreen, MD and Aaron Charles Miller, MD.

Dmand AI links Dr. Hornick to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Bronchiectasis, Mycobacterium avium-intracellulare Infection and Bronchial Diseases. Open Payments lists research payments to Dr. Hornick that name 1 trial.

CMS Open Payments shows 11 general payments to Dr. Hornick from 2 drug and device companies from 2019 to 2024. Consulting fees make up the largest share, 79% of the total. Insmed, Inc. paid the most, $7,745. It also lists 9 research payments totaling $1,725 in 2024, naming 1 clinical trial.

Dr. Hornick graduated from University of Maryland School of Medicine in 1982.